Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study

R Zivadinov, D Jakimovski, M Ramanathan… - Multiple sclerosis and …, 2022 - Elsevier
Background Ocrelizumab is an effective treatment for relapsing and primary-progressive
multiple sclerosis (MS). However, the effect of ocrelizumab on leptomeningeal (LM) …
被引用次数：18 相关文章

Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study.

R Zivadinov, D Jakimovski, M Ramanathan… - Multiple Sclerosis and …, 2022 - europepmc.org
Background Ocrelizumab is an effective treatment for relapsing and primary-progressive
multiple sclerosis (MS). However, the effect of ocrelizumab on leptomeningeal (LM) …

Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study

R Zivadinov, D Jakimovski… - Multiple sclerosis …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Ocrelizumab is an effective treatment for relapsing and primary-progressive
multiple sclerosis (MS). However, the effect of ocrelizumab on leptomeningeal (LM) …

Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study

R Zivadinov, D Jakimovski… - Multiple Sclerosis …, 2022 - msard-journal.com
Background Ocrelizumab is an effective treatment for relapsing and primary-progressive
multiple sclerosis (MS). However, the effect of ocrelizumab on leptomeningeal (LM) …

Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study

R Zivadinov, D Jakimovski… - Multiple Sclerosis …, 2022 - msard-journal.com
Background Ocrelizumab is an effective treatment for relapsing and primary-progressive
multiple sclerosis (MS). However, the effect of ocrelizumab on leptomeningeal (LM) …